Literature DB >> 35559392

Analysis of perioperative complications and related risk factors of thoracotomy and complete video-assisted thoracoscopic surgery lobectomy.

Hongwei Su1, Guorong Yan1, Zijian Li1, Lin Fu2, Lingdi Li2.   

Abstract

OBJECTIVE: To evaluate the perioperative complications and related risk factors of thoracotomy and complete video-assisted thoracoscopic surgery (c-VATS) lobectomy.
METHODS: A total of 93 patients with early lung cancer (LC) treated in our hospital from Mar. 2017 to Mar. 2021 were retrospectively enrolled. Among them, 45 patients underwent conventional thoracotomy lobectomy was classified as the control group (Con group, n=45) and other 48 patients underwent c-VATS lobectomy was classified as the observation group (Obs group, n=48). Surgical indicators of the two groups were compared, and the changes of Visual Analog Scale (VAS) score, plasma levels of vascular endothelial growth factor (VEGF) and interleukin-6 (IL-6), and pulmonary function indexes were compared before and after operation. Additionally, postoperative complications were compared between the two groups. Multivariate logistic regression was carried out to analyse the independent risk factors for postoperative complications.
RESULTS: The Obs group showed significantly less intraoperative blood loss than the Con group and experienced significantly shorter operation time than the Con group (both P<0.001). The Obs group had significantly lower VAS scores than the Con group at 1 day and 7 days after surgery (P<0.05), and showed significantly lower levels of plasma IL-6 and VEGF than the Con group (both P<0.001). In addition, higher forced vital capacity (FVC) and maximum ventilation per minute (MVV) were found in the Obs group than in the Con group (P<0.001), and the Obs group showed a significantly lower incidence of postoperative complications than the Con group (P<0.05). Multivariate logistic regression analysis revealed that age, body mass index (BMI) and operation mode were independent risk factors for postoperative complications.
CONCLUSION: Compared with conventional thoracotomy, c-VATS lobectomy brings a lower incidence of postoperative complications, and age, BMI and operation mode were independent risk factors for postoperative complications. AJTR
Copyright © 2022.

Entities:  

Keywords:  Thoracotomy lobectomy; complete video-assisted thoracoscopic surgery lobectomy; complications; risk factors

Year:  2022        PMID: 35559392      PMCID: PMC9091098     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   3.940


  31 in total

Review 1.  Video-assisted thoracoscopic surgery lobectomy for non-small cell lung cancer.

Authors:  Mingyon Mun; Masayuki Nakao; Yosuke Matsuura; Junji Ichinose; Ken Nakagawa; Sakae Okumura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-07-30

2.  Cancer Progress and Priorities: Lung Cancer.

Authors:  Matthew B Schabath; Michele L Cote
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10       Impact factor: 4.254

3.  Video-Assisted Thoracoscopic Lobectomy Is the Preferred Approach Following Induction Chemotherapy.

Authors:  Mohamed K Kamel; Abu Nasar; Brendon M Stiles; Nasser K Altorki; Jeffrey L Port
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2016-12-20       Impact factor: 1.878

4.  Cancer statistics in China, 2015.

Authors:  Wanqing Chen; Rongshou Zheng; Peter D Baade; Siwei Zhang; Hongmei Zeng; Freddie Bray; Ahmedin Jemal; Xue Qin Yu; Jie He
Journal:  CA Cancer J Clin       Date:  2016-01-25       Impact factor: 508.702

5.  Results of initial low-dose computed tomographic screening for lung cancer.

Authors:  Timothy R Church; William C Black; Denise R Aberle; Christine D Berg; Kathy L Clingan; Fenghai Duan; Richard M Fagerstrom; Ilana F Gareen; David S Gierada; Gordon C Jones; Irene Mahon; Pamela M Marcus; JoRean D Sicks; Amanda Jain; Sarah Baum
Journal:  N Engl J Med       Date:  2013-05-23       Impact factor: 91.245

Review 6.  Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Michael K Gould; Jessica Donington; William R Lynch; Peter J Mazzone; David E Midthun; David P Naidich; Renda Soylemez Wiener
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

7.  What Can We Save for the First-Line Treatment of NSCLC in 2016?

Authors:  David Rossi
Journal:  World J Oncol       Date:  2017-05-04

8.  Risk factors of postoperative pulmonary complications after minimally invasive anatomic resection for lung cancer.

Authors:  Rong Yang; Yihe Wu; Linpeng Yao; Jinming Xu; Siying Zhang; Chengli Du; Feng Chen
Journal:  Ther Clin Risk Manag       Date:  2019-02-04       Impact factor: 2.423

Review 9.  Global Epidemiology of Lung Cancer.

Authors:  Julie A Barta; Charles A Powell; Juan P Wisnivesky
Journal:  Ann Glob Health       Date:  2019-01-22       Impact factor: 2.462

Review 10.  Prospects for population screening and diagnosis of lung cancer.

Authors:  John K Field; Matthijs Oudkerk; Jesper Holst Pedersen; Stephen W Duffy
Journal:  Lancet       Date:  2013-08-24       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.